Wedbush analyst Robert Driscoll initiated coverage of Avalo Therapeutics (AVTX) with an Outperform rating and $18 price target Discover the ...

As Palantir shares tumbled Thursday on expectations of defense spending cuts, some analysts suggested the selloff could be an opportunity to buy the dip.

On Wednesday morning, Wingstop said revenue rose 27%, to $161.8 million. Revenue was below Wall Street forecasts, while earnings were higher than analysts expected, according to FactSet. Wingstop ...

U.S. stocks fell Thursday afternoon, with the S&P 500 (SP500) pulling back from a record high, in part as investors balked at ...

Palantir stock is continuing to slide Thursday as investors weigh a CEO stock sale and potential defense budget cuts. Here’s ...

Principal Securities Inc. raised its position in shares of VICI Properties Inc. (NYSE:VICI – Free Report) by 32.6% in the ...

Apple's iPhone 16e is priced higher than expected - but it has AI Apple Inc.'s newest lower-priced iPhone costs more than Wall Street expected, but it includes artificial-intelligence features ...

Some on Wall Street were expecting Apple (AAPL) to price the new iPhone at around $500. The $599 price is lower than the $799 starting price of the iPhone 16 but is about $50 more than Wedbush ...

Dan Ives, Wedbush Securities global head of technology research, joins CNBC's 'Squawk on the Street' to break down ...

Dan Ives, Managing Director and Senior Equity Analyst at Wedbush Securities, shares his expert insights on the future of AI, ...